Featured Research

from universities, journals, and other organizations

Molecular mechanism for some anti-arrhythmia drugs discovered

Date:
June 15, 2011
Source:
University of British Columbia
Summary:
Researchers -- using an innovative, atom-by-atom substitution method -- have uncovered the mechanism by which a particular class of drugs controls irregular heartbeats.

University of British Columbia researchers -- using an innovative, atom-by-atom substitution method -- have uncovered the mechanism by which a particular class of drugs controls irregular heartbeats.

The findings, published June 14 in the online journal Nature Communications, shed light on why certain anti-arrhythmic drugs (AADs) have dramatically different effects on the heart's behavior compared to others, and why the same drug can be beneficial in some instances and fatal in others. The discovery points the way toward development of better treatments for the condition, which is a leading cause of stroke.

AADs are typically categorized on the basis of their effects on the electrocardiogram (ECG), not on their inherent qualities or molecular mechanisms. Such sorting of drugs, while common in pharmacology, limits our ability to improve upon them, said principal investigator Chris Ahern, an Assistant Professor in the UBC Department of Anesthesiology, Pharmacology and Therapeutics.

"By understanding how these drugs work at the molecular level, we will be better able to pick and choose the traits we want -- and those we don't -- when developing new drugs for this dangerous condition," said Ahern, who is a member of the Life Sciences Institute at UBC and of the Brain Research Centre at UBC and the Vancouver Coastal Health Research Institute.

All three categories of Class 1 AADs, called Class 1a, 1b and 1c, bind to the same site within the cardiac sodium channel, a sophisticated protein that generates electrical impulses to the heart. Ahern, working with postdoctoral fellow Stephan Pless, in the same department, and Jason Galpin and Adam Frankel from the Faculty of Pharmaceutical Sciences, sought to discover whether the differences were due to varying levels of electrostatic interactions between the drugs and the amino acids in the channel.

They created artificial amino acids to mirror the behavior of the cardiac sodium channel, probing the AADs' structure and the contribution of electrical charge -- a technique that follows in the footsteps of UBC Nobel Laureate Michael Smith and has been used successfully by a few labs worldwide. The researchers substituted individual hydrogen atoms with fluorine atoms, which display different electrical characteristics, to see if those modifications affect the AADs' ability to bind to the cardiac sodium channel.

The various alterations of the amino acids were introduced into cells, and the researchers measured the resulting electrical current. They found that each substitution of a hydrogen atom with a fluorine atom lowered the level of AAD binding to the cardiac sodium channel.

"We did this in steps, and observed a clear trend with the Class 1b AADs," said Pless, who has been working at UBC since 2008 on a research fellowship from the Heart & Stroke Foundation of BC & Yukon. "The trend held over each atom replacement, which confirmed that electrostatic reactions are indeed taking place with the drugs. But we found little evidence of the same electrical interaction with 1a and 1c drugs."

The distinction of 1b drugs explains their particular ability to both rapidly change the heart's behaviour, and to rapidly "shut off," Pless said.

"By zeroing in on these molecular actions, drug developers will be better able to isolate the most desirable qualities of each drug -- as well as the most threatening -- to find a more effective, safer version," he said.


Story Source:

The above story is based on materials provided by University of British Columbia. Note: Materials may be edited for content and length.


Journal Reference:

  1. Stephan A. Pless, Jason D. Galpin, Adam Frankel, Christopher A. Ahern. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels. Nature Communications, 2011; 2: 351 DOI: 10.1038/ncomms1351

Cite This Page:

University of British Columbia. "Molecular mechanism for some anti-arrhythmia drugs discovered." ScienceDaily. ScienceDaily, 15 June 2011. <www.sciencedaily.com/releases/2011/06/110614115033.htm>.
University of British Columbia. (2011, June 15). Molecular mechanism for some anti-arrhythmia drugs discovered. ScienceDaily. Retrieved April 24, 2014 from www.sciencedaily.com/releases/2011/06/110614115033.htm
University of British Columbia. "Molecular mechanism for some anti-arrhythmia drugs discovered." ScienceDaily. www.sciencedaily.com/releases/2011/06/110614115033.htm (accessed April 24, 2014).

Share This



More Health & Medicine News

Thursday, April 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Fungus Killing Bats, Spreading in US

Deadly Fungus Killing Bats, Spreading in US

AP (Apr. 24, 2014) A disease that has killed more than six million cave-dwelling bats in the United States is on the move and wildlife biologists are worried. White Nose Syndrome, discovered in New York in 2006, has now spread to 25 states. (April 24) Video provided by AP
Powered by NewsLook.com
Companies Ramp Up Wellness to Lower Health Costs

Companies Ramp Up Wellness to Lower Health Costs

AP (Apr. 24, 2014) That little voice telling you to exercise, get in shape and get healthy is probably coming from your boss. More companies are beefing up wellness programs to try and cut down their health care costs. (April 24) Video provided by AP
Powered by NewsLook.com
Blood From World's Oldest Woman Suggests Life Limit

Blood From World's Oldest Woman Suggests Life Limit

Newsy (Apr. 24, 2014) Scientists say for the extremely elderly, their stem cells might reach a state of exhaustion. This could limit one's life span. Video provided by Newsy
Powered by NewsLook.com
FDA Wants To Ban Sales Of E-Cigarettes To Minors

FDA Wants To Ban Sales Of E-Cigarettes To Minors

Newsy (Apr. 24, 2014) The Food and Drug Administration wants to crack down on the use of e-cigarettes, banning the sale of the product to minors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins